Epidermolysis Bullosa: Classification and Wound Management

Epidermolysis Bullosa (EB) is a group of inherited skin disorders characterized by extreme fragility of the skin and mucous membranes, leading to blister formation with minimal trauma. Management focuses on wound care, preventing infection, and addressing complications associated with this chronic condition.

Topics: EB, genodermatosis, blistering

Overview / Definition Epidermolysis Bullosa is a heterogeneous group of genetic disorders characterized by skin fragility and blistering resulting from mechanical trauma. The blisters form within the epidermis or dermis due to defects in structural proteins that maintain skin integrity. Epidemiology The prevalence of EB is estimated to be 1 in 20,000 live births, with varying incidence rates depending on the subtype. The severity and distribution of the disease can differ significantly among affected individuals. Commonly affects both sexes equally. Incidence may vary by geographic region and ethnic background. Pathophysiology / Mechanism The pathophysiology of EB is primarily due to mutations in genes encoding proteins critical for dermal-epidermal adhesion. The main forms include: Epidermolysis Bullosa Simplex (EBS): Caused by mutations in keratin genes (KRT5, KRT14). Dystrophic Epidermolysis Bullosa (DEB): Related to mutations in the COL7A1 gene affecting collagen type VII. Junctional Epidermolysis Bullosa (JEB): Associated with genes such as LAMA3, LAMB3, and LAMC2. Kindler Syndrome: A mixed EB type associated with mutations in the FERMT1 gene. Clinical Presentation Patients present with blistering and erosions that can occur spontaneously or due to minor trauma. Key clinical features include: Blisters on the skin and mucous membranes. Chronic wounds and scarring. Nail dystrophy and dental abnormalities in some subtypes. Severity can range from mild (localized blistering) to severe (widespread blistering and systemic involvement). Diagnosis / Workup Diagnosis is primarily clinical but can be confirmed through: Skin Biopsy: Histological examination shows the level of blister formation. Direct Immunofluorescence: Helps differentiate between types of EB. Genetic Testing: Identifies specific mutations for precise classification. Treatment / Management Management strategies focus on wound care and preventing complications. Key treatment steps include: Wound Care: Use